For instance, overexpression of miR-210 in exosomes derived lung cancer patients activates the JAK2/STAT3 pathway, resulting in increased expression of pro-angiogenic factors such as MMP9, FGF2, and vascular endothelial growth factor (VEGF) (64). This evidence concerns the gene VEGFA and lung cancer.